|

Atezolizumab plus Bevacizumab Clinical Trials

3 actively recruiting trials

Also known as: atezolizumab-bevacizumab; Atez/Bev treatment

Pipeline

Phase 2: 2

Top Sponsors

  • Third Affiliated Hospital, Sun Yat-Sen University1
  • Chinese University of Hong Kong1
  • Asan Medical Center1

Indications

  • Cancer3
  • Liver Disease2
  • Liver Cancer2
  • Hepatocellular Carcinoma2
  • Tumor Thrombus1

Other3 trials

Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion
Phase 2
SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis
Phase 2
TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.